The best indicator for Steris (STE)
We backtested 20 indicators across daily, weekly and hourly charts on real Steris (STE) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Stochastic
On the daily chart, this is the strongest risk-adjusted edge we found for Steris (STE) over ~34.0 years — trailing buy-and-hold by 4.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Daily | 11.6% | 0.58 | -45.0% | 72.0% | 168 | -4.1% |
| 2 | WaveTrend (8/6/4) ✓ | Daily | 12.8% | 0.58 | -59.5% | 75.6% | 127 | -2.9% |
| 3 | Money Flow Index ✓ | Daily | 11.4% | 0.57 | -44.3% | 73.2% | 41 | -4.3% |
| 4 | Holy Grail Confluence ✓ | Daily | 11.3% | 0.57 | -56.0% | 83.9% | 56 | -4.4% |
| 5 | RSI Mean-Reversion ✓ | Daily | 7.8% | 0.56 | -43.7% | 84.0% | 50 | -7.9% |
| 6 | CCI ✓ | Daily | 11.3% | 0.56 | -36.3% | 71.5% | 165 | -4.4% |
| 7 | Williams %R ✓ | Daily | 11.1% | 0.55 | -50.1% | 71.5% | 221 | -4.6% |
| 8 | CCI ✓ | Weekly | 9.6% | 0.55 | -69.3% | 82.9% | 41 | -5.6% |
| 9 | Bollinger Mean-Reversion ✓ | Daily | 7.9% | 0.47 | -38.3% | 68.8% | 144 | -7.8% |
| 10 | Bollinger Mean-Reversion ✓ | Weekly | 6.5% | 0.47 | -39.0% | 72.7% | 22 | -8.7% |
| 11 | WaveTrend (8/6/4) ✓ | Weekly | 6.6% | 0.43 | -59.0% | 72.0% | 25 | -8.6% |
| 12 | Stochastic ✓ | Weekly | 6.3% | 0.42 | -54.6% | 81.8% | 33 | -8.9% |
| 13 | EMA 20/50 Cross ✓ | Weekly | 8.7% | 0.43 | -61.1% | 46.2% | 13 | -6.5% |
| 14 | Williams %R ✓ | Weekly | 5.3% | 0.36 | -61.1% | 75.0% | 44 | -9.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Steris (STE), Stochastic on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.